Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.


TSXV:NU.H - Post by User

Post by johncolton Dec 10, 2020 4:28pm
110 Views
Post# 32080657

Today's news release full script

Today's news release full script

NeutriSci Provides Update on Washington State Approval and Expansion into Oklahoma

Thursday, December 10, 2020 11:30 AM
Share this article now
  
Topic:
 
Consumer & Retail Products
 

VANCOUVER, BC / ACCESSWIRE / December 10, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, is pleased to provide an update on the latest developments with its US manufacturing and distribution partner, Cryopharm Corp. ("Cryopharm").

Washington State

The Department of Agriculture in the State of Washington has given its approval for the manufacturing, distribution and sale of the entire Cryopharm product line which is powered by NeutriSci's ingredients and technology. The approved products include Marbl Melts™, Kali Juice™, Caf Maria as well NeutriSci's Kushtabs™ and Zenstix™. Distribution and sales of the products are expected to start in Q1/2021. The products will be dispensed in approximately 400 locations across the State of Washington.

Washington state has seen gross sales of cannabis products grow exponentially over the past 5 years; starting in 2014 with sales of $31 million exploding to over a billion in 2019.

Oklahoma

NeutriSci is also pleased to announce that Cryopharm has signed a definitive agreement with a contract manufacturer to manufacture, distribute and sell the product lines in the State of Oklahoma. Production, distribution and sales are expected to take place in Q1/2021. Like Washington, sales will include Marbl Melts™, Kali Juice™, Caf Maria as well NeutriSci's Kushtabs™ and Zenstix™. All of which are using NeutriSci's ingredients and technology.

Oklahoma is home to the second most dispensaries per capita, which equals 15.6 dispensaries per 100,000 residents. In 2019, the first full year of Oklahoma cannabis sales, the total number of sales reached $365 million. The sales amount is estimated to increase to $950 million by 2025. By comparison, Pennsylvania is estimating $770 million in 2025.

Glen Rehman, CEO of NeutriSci, stated: "We are very pleased that the Department of Agriculture has approved our ingredients, technologies and form factors for the distribution and sale of the products in the State of Washington. While sales in California are picking up, we are equally excited that the Oklahoma deal has been completed and will open the door to another lucrative state with increasing sales and distribution. We will continue to expand the brands into additional US states over the coming months."

*https://cannacon.org/oklahoma-cannabis-boom/

About NeutriSci International Inc.

NeutriSci specializes in the innovation, production, and formulation of nutraceutical products. Established in 2009, NeutriSci's is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy®, the Company's natural energy and focus supplement that has at its core, the beneficial effects of blueberries. For more information, please visit: www.neutrisci.com.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.
Glen Rehman
CEO
Tel: (403) 264-6320

For investor inquiries, please contact investors@neutrisci.com


<< Previous
Bullboard Posts
Next >>